ARTIFICIAL INTELLIGENCE

Medly Raises $8m to Expand AI-Powered Education Platform

The London education technology company is expanding into United States exam preparation and building an evidence base for its AI tutoring platform.

James Taylor
Private Markets Group Ltd
24 August 2026 · 4 min read
Repeating NEWS wordmark graphic in red and blue — UK Private Wealth Magazine News Desk

Medly AI, a London-based learning platform, has raised an $8 million (approximately €6.9 million) Seed round led by Felix Capital, with existing investors Eka Ventures and Ada Ventures participating. Angel investors in the round include Andrey Dobrynin, chief executive of InvestEngine; Al Giles, venture partner at Creator Fund; Jean Hammond, general partner at LearnLaunch Accelerator; and Hector Mason, general partner at Episode 1 Ventures.

The company was founded by UCL medicine graduates Dr Paul Jung and Dr Kavi Samra, who left careers in the NHS to build the platform. Medly provides on-demand tutoring for students preparing for GCSE, IGCSE, A-Level and International Baccalaureate examinations, and operates a curriculum-agnostic product, Medly Open, for university students.

What the funding will support

Medly said the capital will fund growth in the United Kingdom, international expansion and further research. In the United States the company has launched SAT preparation and plans to add AP and ACT coverage by the end of the year. It also intends to develop proprietary models for specific UK and EEA educational functions such as marking and pedagogy, and to add features aimed at students working beyond the standard examination curriculum.

The company says its tutor is built on a proprietary combination of seven large language models, tracks student progress and adapts feedback style, and includes handwriting recognition so students can work directly on a tablet in subjects such as mathematics and chemistry. Medly positions the product as purpose-built and accuracy-tested support, in contrast to general-purpose generative AI tools.

Company-reported performance

The following figures are as reported by Medly and have not been independently verified. The company states that, among students who used the platform for GCSE preparation last summer, 74% improved by at least one grade and 41% improved by two or more grades, with the largest improvements in Physics and English Literature. It also reports that its user base has grown by almost 600% since launching in February 2025, to more than 400,000 users in the United Kingdom.

Medly says it has published a first research paper comparing its marking performance with human examiners, and has completed a randomised controlled trial with more than 1,000 UK students examining attainment in lower-attaining schools. The company was awarded a grant under the Department for Education's AI Tutoring Tools Pioneers Programme in July, a scheme directed at attainment among disadvantaged pupils in England.

Why it matters for private capital

Education technology has a long record of adoption without demonstrated attainment gains, which is why the evidence programme matters more than the growth figures here. For investors examining the AI application layer, the relevant question is whether outcome data can be produced to a standard institutional buyers accept — the difference between a consumer subscription business and one procured by schools and public bodies.

Reported by the UK Private Wealth Magazine News Desk from company and investor information. Figures, performance data and forward-looking statements are attributed to the parties named. This article is provided for information only and does not constitute investment advice.
Subscribe FreeView Latest Edition